Triptorelin

63 interactions 4 explained in plain English
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Jul 4, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Eribulin Injection Ofloxacin Felbamate Oxaliplatin Injection Amisulpride Injection Ivabradine
63 Major
All (63) Major (63)

Major

Triptorelin Ivabradine Corlanor Increased risk of QT interval prolongation Details Triptorelin Ketoconazole Topical Extina® Foam Increased risk of QT interval prolongation Details Triptorelin Lefamulin Xenleta Increased risk of QT interval prolongation Details Triptorelin Lenvatinib Lenvima Increased risk of QT-interval prolongation Details Triptorelin Levofloxacin Levaquin Increased risk of QT interval prolongation Details Triptorelin Levofloxacin Injection Levaquin Increased risk of QT interval prolongation Details Triptorelin Loperamide Diamode An increased risk of QT interval prolongation, which may increase risk of cardiotoxicity (torsade de pointes, cardiac arrest) Details Triptorelin Mefloquine Lariam® Increased risk of QT interval prolongation Details Triptorelin Metronidazole Flagyl Increased risk of QT interval prolongation Details Triptorelin Metronidazole Injection Flagyl Increased risk of QT interval prolongation Details Triptorelin Metronidazole Topical MetroCream® Increased risk of QT interval prolongation Details Triptorelin Metronidazole Vaginal MetroGel® Vaginal Increased risk of QT interval prolongation Details Triptorelin Moxifloxacin Avelox Increased risk of QT interval prolongation Details Triptorelin Moxifloxacin Injection Avelox Increased risk of QT interval prolongation Details Triptorelin Moxifloxacin Ophthalmic Moxeza® Increased risk of QT interval prolongation Details Triptorelin Nafarelin Nasal Spray Synarel Increased risk of QT interval prolongation Details Triptorelin Octreotide Bynfezia Increased risk of QT interval prolongation Details Triptorelin Octreotide Injection Bynfezia Increased risk of QT interval prolongation Details Triptorelin Ofloxacin Floxin® Increased risk of QT interval prolongation Details Triptorelin Ofloxacin Ophthalmic Ocuflox Increased risk of QT interval prolongation Details Triptorelin Ofloxacin Otic Floxin® Otic Increased risk of QT interval prolongation Details Triptorelin Olodaterol Oral Inhalation Striverdi An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Triptorelin Oxaliplatin Injection Eloxatin® Increased risk of QT-interval prolongation Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.